Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0AF8E
|
|||
| Drug Name |
BXCL101
|
|||
| Indication | Neurofibromatosis type 2 [ICD-11: LD2D.11] | Phase 1/2 | [1] | |
| Company |
BioXcel Branford, CT
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.